Press releases
- Press releases
- Browse
Press releases
First part of multi-stage lead generation project, for novel Nitric Oxide synthase inhibitors, now completed More
Study grant will allow doctors to determine specific causes of pain and establish best practices for pain treatment More
Biochemical marker for brain damage (BMBD) More
CeNeS Pharmaceuticals plc (LSE: CEN) announces spin-out of cognitive testing division as part of ongoing restructuring programme More
Related Reports
Market Research Reports provided by reports.iptechex.com
Sep 2011 - 97 pages - $3,500
Oct 2010 - 53 pages - $1,000
Aug 2008 - 110 pages - $1,040
Aug 2008 - 352 pages - $2,615
Dec 2008 - 25 pages - $200
Jan 2010 - $75
Jun 2006 - 1068 pages - $2,495
Jul 2011 - 98 pages - $5,700
Jun 2011 - 99 pages - $5,700
Feb 2012 - 1350 pages - $2,695
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- CNS trauma
- Diabetic neuropathy
- Fibromyalgia
- Muscular dystrophy
- Myasthenia gravis
- Peripheral neuropathy
- Sexual dysfunction
- Smoking cessation
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us